Concertai

Concertai company information, Employees & Contact Information

Explore related pages

Related company profiles:

ConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai™ technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies. TeraRecon® provides advanced radiological image visualizations and clinical AI decision augmentation solutions for MRI and CT. CancerLinQ® is an Initiative of ConcertAI, providing oncology providers with ASCO-aligned automated QOPI and ASCO Certified® quality solutions and SmartLinQ™ analytic services.
Looking for a particular Concertai employee's phone or email?

Concertai Questions

News

ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology - citybiz

ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology citybiz

ConcertAI Appoints Michael Myshrall as Chief Financial Officer - Business Wire

ConcertAI Appoints Michael Myshrall as Chief Financial Officer Business Wire

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and - GlobeNewswire

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and GlobeNewswire

Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer - HMP Global Learning Network

Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer HMP Global Learning Network

ConcertAI Provides Intelligent Automation of ASCO Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ SmartLinQ™ Solutions - Business Wire

ConcertAI Provides Intelligent Automation of ASCO Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ SmartLinQ™ Solutions Business Wire

ConcertAI Appoints Eron Kelly as CEO - citybiz

ConcertAI Appoints Eron Kelly as CEO citybiz

Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform - PR Newswire

Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform PR Newswire

Life Sciences and Healthcare Leader ConcertAI Raises $150 Million Series C from Sixth Street at $1.9 Billion Valuation - Sixth Street

Life Sciences and Healthcare Leader ConcertAI Raises $150 Million Series C from Sixth Street at $1.9 Billion Valuation Sixth Street

Inside NVIDIA and ConcertAI's partnership to build AI agents for oncology trials - drugdiscoverytrends.com

Inside NVIDIA and ConcertAI's partnership to build AI agents for oncology trials drugdiscoverytrends.com

ConcertAI Introduces New Artificial Intelligence Solutions Powered by Real-World Data at ASCO 2024 - Applied Clinical Trials

ConcertAI Introduces New Artificial Intelligence Solutions Powered by Real-World Data at ASCO 2024 Applied Clinical Trials

ConcertAI, Bayer join forces to advance precision oncology - Mobi Health News

ConcertAI, Bayer join forces to advance precision oncology Mobi Health News

ConcertAI Launches New Generative and Agentic AI-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences - Business Wire

ConcertAI Launches New Generative and Agentic AI-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences Business Wire

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology - Business Wire

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology Business Wire

Jennifer Rider Appointed ConcertAI Head of Real-World Evidence Services - citybiz

Jennifer Rider Appointed ConcertAI Head of Real-World Evidence Services citybiz

ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025 - Business Wire

ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025 Business Wire

ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers - Business Wire

ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers Business Wire

Exigent Research, Leading National Community Research Network, Partners with AI Leader ConcertAI to Integrate CARAai™ Precision Trial Solutions - Business Wire

Exigent Research, Leading National Community Research Network, Partners with AI Leader ConcertAI to Integrate CARAai™ Precision Trial Solutions Business Wire

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research - Business Wire

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research Business Wire

ConcertAI Appoints James Salitan as General Counsel - Business Wire

ConcertAI Appoints James Salitan as General Counsel Business Wire

After more than a decade, ASCO sells CancerLinQ to ConcertAI - The Cancer Letter

After more than a decade, ASCO sells CancerLinQ to ConcertAI The Cancer Letter

Mike Rossi Joins ConcertAI as Chief Financial Officer, Bringing Deep Healthcare and Life Sciences Experience; Public Company Expertise - PR Newswire

Mike Rossi Joins ConcertAI as Chief Financial Officer, Bringing Deep Healthcare and Life Sciences Experience; Public Company Expertise PR Newswire

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development - BioSpace

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development BioSpace

Identification of predictive subphenotypes for clinical outcomes using real world data and machine learning - Nature

Identification of predictive subphenotypes for clinical outcomes using real world data and machine learning Nature

ASCO: ConcertAI announces Nvidia partnership, launches new AI tools - Fierce Biotech

ASCO: ConcertAI announces Nvidia partnership, launches new AI tools Fierce Biotech

ConcertAI Names Claudio D’Ambrosio, PhD, as Chief Revenue Officer - citybiz

ConcertAI Names Claudio D’Ambrosio, PhD, as Chief Revenue Officer citybiz

Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals - Nature

Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals Nature

ConcertAI taps new CFO - AuntMinnie

ConcertAI taps new CFO AuntMinnie

ConcertAI names new CEO - AuntMinnie

ConcertAI names new CEO AuntMinnie

ConcertAI Names Ronan Brown as Chief Operations Officer - citybiz

ConcertAI Names Ronan Brown as Chief Operations Officer citybiz

ConcertAI expands multimodal data, RWD management - AuntMinnie

ConcertAI expands multimodal data, RWD management AuntMinnie

Behavior of test specificity under an imperfect gold standard: findings from a simulation study and analysis of real-world oncology data - BMC Medical Research Methodology

Behavior of test specificity under an imperfect gold standard: findings from a simulation study and analysis of real-world oncology data BMC Medical Research Methodology

TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform - Yahoo Finance

TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform Yahoo Finance

How ConcertAI aims to elevates CancerLinQ - drugdiscoverytrends.com

How ConcertAI aims to elevates CancerLinQ drugdiscoverytrends.com

Overall Survival in EGFR-Mutant Advanced NSCLC Treated With First-Line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in the United States - ScienceDirect.com

Overall Survival in EGFR-Mutant Advanced NSCLC Treated With First-Line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in the United States ScienceDirect.com

ConcertAI debuts latest clinical trial software upgrade to improve studies - Fierce Biotech

ConcertAI debuts latest clinical trial software upgrade to improve studies Fierce Biotech

JPM23: Caris teams up with ConcertAI on cancer trial data platforms - Fierce Biotech

JPM23: Caris teams up with ConcertAI on cancer trial data platforms Fierce Biotech

Labcorp taps ConcertAI for next-gen approach to clinical trials - Fierce Biotech

Labcorp taps ConcertAI for next-gen approach to clinical trials Fierce Biotech

ConcertAI hits $1.9B valuation with $150M series C for real-world data cancer research tools - Fierce Healthcare

ConcertAI hits $1.9B valuation with $150M series C for real-world data cancer research tools Fierce Healthcare

ConcertAI and Janssen deepen data-science collaboration - drugdiscoverytrends.com

ConcertAI and Janssen deepen data-science collaboration drugdiscoverytrends.com

ConcertAI scores $150M, valuation skyrockets to nearly $2B - Mobi Health News

ConcertAI scores $150M, valuation skyrockets to nearly $2B Mobi Health News

Healthcare-focused AI and data startup ConcertAI bags $150M in Series C funding - SiliconANGLE

Healthcare-focused AI and data startup ConcertAI bags $150M in Series C funding SiliconANGLE

AI oncology startup ConcertAI raises $150M in Series C funding - drugdiscoverytrends.com

AI oncology startup ConcertAI raises $150M in Series C funding drugdiscoverytrends.com

ConcertAI, a Startup Focused on Cancer Research, Raises $150 Million - The Wall Street Journal

ConcertAI, a Startup Focused on Cancer Research, Raises $150 Million The Wall Street Journal

ConcertAI integrates with imaging technology specialist TeraRecon - drugdiscoverytrends.com

ConcertAI integrates with imaging technology specialist TeraRecon drugdiscoverytrends.com

AI-Based Clinical Trial Screening Is More Than 3X Faster Than Traditional Methods - AiThority

AI-Based Clinical Trial Screening Is More Than 3X Faster Than Traditional Methods AiThority

Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence - FinancialContent

Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence FinancialContent

Racial disparities in Covid-19 are bad. They’re even worse in cancer - statnews.com

Racial disparities in Covid-19 are bad. They’re even worse in cancer statnews.com

ConcertAI hires Jitendra Gupta as first managing director of India - Business Standard

ConcertAI hires Jitendra Gupta as first managing director of India Business Standard

Top Concertai Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant